Is Nuvalent Stock a Good Investment?
Nuvalent Investment Advice | NUVL |
- Examine Nuvalent's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Nuvalent's leadership team and their track record. Good management can help Nuvalent navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Nuvalent's business and its evolving consumer preferences.
- Compare Nuvalent's performance and market position to its competitors. Analyze how Nuvalent is positioned in terms of product offerings, innovation, and market share.
- Check if Nuvalent pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Nuvalent's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Nuvalent stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Nuvalent is a good investment.
Sell | Buy |
Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Nuvalent Stock
Researching Nuvalent's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.79. Nuvalent had not issued any dividends in recent years.
To determine if Nuvalent is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nuvalent's research are outlined below:
| Nuvalent appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (126.22 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nuvalent currently holds about 256.96 M in cash with (99.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.31. | |
| Nuvalent has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Nuvalents chief development officer Noci Darlene sells 442,980 in shares |
Nuvalent uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nuvalent. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nuvalent's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Nuvalent's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Nuvalent's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-05-12 | 2022-03-31 | -0.4 | -0.36 | 0.04 | 10 | ||
2022-03-29 | 2021-12-31 | -0.32 | -0.36 | -0.04 | 12 | ||
2023-03-16 | 2022-12-31 | -0.43 | -0.49 | -0.06 | 13 | ||
2023-05-11 | 2023-03-31 | -0.51 | -0.44 | 0.07 | 13 | ||
2024-08-08 | 2024-06-30 | -0.76 | -0.88 | -0.12 | 15 | ||
2021-11-10 | 2021-09-30 | -0.25 | -0.39 | -0.14 | 56 | ||
2021-09-08 | 2021-06-30 | -0.19 | -3.17 | -2.98 | 1568 |
Know Nuvalent's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nuvalent is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuvalent backward and forwards among themselves. Nuvalent's institutional investor refers to the entity that pools money to purchase Nuvalent's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Woodline Partners Lp | 2024-06-30 | 886.1 K | Geode Capital Management, Llc | 2024-06-30 | 782.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 773.3 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 754.1 K | Driehaus Capital Management Llc | 2024-06-30 | 696.6 K | Wellington Management Company Llp | 2024-06-30 | 611.4 K | Fred Alger Management, Llc | 2024-06-30 | 578.1 K | Pictet Asset Manangement Sa | 2024-06-30 | 568.9 K | Silverarc Capital Management, Llc | 2024-06-30 | 465.7 K | Deerfield Management Co | 2024-06-30 | 20 M | Fmr Inc | 2024-06-30 | 8.9 M |
Nuvalent's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.66 B.Market Cap |
|
Nuvalent's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.17) | (0.18) | |
| Return On Capital Employed | (0.21) | (0.20) | |
| Return On Assets | (0.17) | (0.18) | |
| Return On Equity | (0.18) | (0.17) |
Determining Nuvalent's profitability involves analyzing its financial statements and using various financial metrics to determine if Nuvalent is a good buy. For example, gross profit margin measures Nuvalent's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nuvalent's profitability and make more informed investment decisions.
Evaluate Nuvalent's management efficiency
Nuvalent has return on total asset (ROA) of (0.2271) % which means that it has lost $0.2271 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3281) %, meaning that it created substantial loss on money invested by shareholders. Nuvalent's management efficiency ratios could be used to measure how well Nuvalent manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.18. Return On Capital Employed is expected to rise to -0.2 this year. At this time, Nuvalent's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 559 M this year, although the value of Other Current Assets will most likely fall to about 3.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 12.03 | 12.63 | |
| Tangible Book Value Per Share | 12.03 | 12.63 | |
| Enterprise Value Over EBITDA | (26.42) | (27.74) | |
| Price Book Value Ratio | 6.12 | 6.42 | |
| Enterprise Value Multiple | (26.42) | (27.74) | |
| Price Fair Value | 6.12 | 6.42 | |
| Enterprise Value | 1.1 B | 778 M |
The leadership approach at Nuvalent's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 1.328 |
Basic technical analysis of Nuvalent Stock
As of the 12th of November 2024, Nuvalent secures the Downside Deviation of 2.84, risk adjusted performance of 0.1016, and Mean Deviation of 2.39. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuvalent, as well as the relationship between them. Please verify Nuvalent jensen alpha and downside variance to decide if Nuvalent is priced some-what accurately, providing market reflects its recent price of 94.39 per share. Given that Nuvalent has jensen alpha of 0.2838, we recommend you to check Nuvalent's last-minute market performance to make sure the company can sustain itself at a future point.Nuvalent's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvalent insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvalent's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuvalent insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nuvalent's Outstanding Corporate Bonds
Nuvalent issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nuvalent uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nuvalent bonds can be classified according to their maturity, which is the date when Nuvalent has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| NUTRIEN LTD 3 Corp BondUS67077MAD02 | View | |
| NUTRIEN LTD 4 Corp BondUS67077MAE84 | View | |
| NTRCN 395 13 MAY 50 Corp BondUS67077MAX65 | View | |
| NTRCN 595 07 NOV 25 Corp BondUS67077MAY49 | View | |
| US67077MAZ14 Corp BondUS67077MAZ14 | View | |
| NUTRIEN LTD Corp BondUS67077MAT53 | View | |
| NUTRIEN LTD Corp BondUS67077MAU27 | View |
Understand Nuvalent's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Nuvalent's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1016 | |||
| Market Risk Adjusted Performance | 0.3677 | |||
| Mean Deviation | 2.39 | |||
| Semi Deviation | 2.4 | |||
| Downside Deviation | 2.84 | |||
| Coefficient Of Variation | 815.69 | |||
| Standard Deviation | 4.41 | |||
| Variance | 19.49 | |||
| Information Ratio | 0.0826 | |||
| Jensen Alpha | 0.2838 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.1286 | |||
| Treynor Ratio | 0.3577 | |||
| Maximum Drawdown | 36.85 | |||
| Value At Risk | (4.61) | |||
| Potential Upside | 4.64 | |||
| Downside Variance | 8.04 | |||
| Semi Variance | 5.78 | |||
| Expected Short fall | (2.83) | |||
| Skewness | 3.79 | |||
| Kurtosis | 23.94 |
| Risk Adjusted Performance | 0.1016 | |||
| Market Risk Adjusted Performance | 0.3677 | |||
| Mean Deviation | 2.39 | |||
| Semi Deviation | 2.4 | |||
| Downside Deviation | 2.84 | |||
| Coefficient Of Variation | 815.69 | |||
| Standard Deviation | 4.41 | |||
| Variance | 19.49 | |||
| Information Ratio | 0.0826 | |||
| Jensen Alpha | 0.2838 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.1286 | |||
| Treynor Ratio | 0.3577 | |||
| Maximum Drawdown | 36.85 | |||
| Value At Risk | (4.61) | |||
| Potential Upside | 4.64 | |||
| Downside Variance | 8.04 | |||
| Semi Variance | 5.78 | |||
| Expected Short fall | (2.83) | |||
| Skewness | 3.79 | |||
| Kurtosis | 23.94 |
Consider Nuvalent's intraday indicators
Nuvalent intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nuvalent stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 7840.44 | |||
| Daily Balance Of Power | (0.41) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 94.99 | |||
| Day Typical Price | 94.79 | |||
| Price Action Indicator | (1.11) | |||
| Period Momentum Indicator | (1.03) |
Nuvalent Corporate Filings
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 4th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 17th of September 2024 Other Reports | ViewVerify | |
8K | 16th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Nuvalent Stock media impact
Far too much social signal, news, headlines, and media speculation about Nuvalent that are available to investors today. That information is available publicly through Nuvalent media outlets and privately through word of mouth or via Nuvalent internal channels. However, regardless of the origin, that massive amount of Nuvalent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nuvalent news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nuvalent relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nuvalent's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nuvalent alpha.
Nuvalent Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Nuvalent can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Nuvalent Historical Investor Sentiment
Investor biases related to Nuvalent's public news can be used to forecast risks associated with an investment in Nuvalent. The trend in average sentiment can be used to explain how an investor holding Nuvalent can time the market purely based on public headlines and social activities around Nuvalent. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Nuvalent's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Nuvalent and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Nuvalent news discussions. The higher the estimate score, the more favorable the investor's outlook on Nuvalent.
Nuvalent Corporate Management
| Darlene Noci | Chief Officer | Profile | |
| Perrin BS | Senior Strategy | Profile | |
| Prof Shair | Head Founder | Profile | |
| John Soglia | Senior Development | Profile | |
| Christopher MD | Chief Officer | Profile | |
| Deborah JD | Chief Secretary | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Return On Assets (0.23) | Return On Equity (0.33) |
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Nuvalent's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.